Compared with the COPD rats treated with NAC + oe-VWF + sh-NC, the weight of the COPD rats treated with NAC + oe-VWF + sh-p38 MAPK increased (Fig. 7A). This evidence concerns the gene VWF and chronic obstructive pulmonary disease.